The evaluation of the Myxovirus Resistance 1 protein in serum and saliva to monitor disease activation in primary Sjögren’s syndrome. Clinics [Internet]. 2019 Jun. 26 [cited 2024 May 3];74:e631. Available from: https://revistas.usp.br/clinics/article/view/159385